Large-scale testing (Phase 3)Ended earlyNCT02579265
What this trial is testing
Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants
Who this might be right for
Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days
Fresenius Kabi 204